Homepage Banner Raps 2026 2
Logo Raps Ric

RegASK will be speaking at the RAPS Regulatory Intelligence Conference 2026

Meet us there

Get your copy of the 2026 State of Regulatory Affairs and Compliance Report

RegASK Launches AI-Assisted Label Review for Instant, Global Compliance

Read all about it
Home Page 01

Vertical-Specific
AI For Regulatory Teams

Empowering faster, smarter regulatory decisions for Life Sciences and Consumer Products teams.

Learn more → Book a demo
Home Image 1

What we deliver

RegASK’s AI-driven regulatory intelligence platform combines agentic AI, the 1st vertical LLMs, and a community of 1700+ subject matter experts to deliver triaged regulatory alerts, tailored impact assessments, and end-to-end workflow orchestration.

This improves compliance outcomes, mitigates risks, and accelerates time to market across more than 160+ countries.

Bunge logo Fibronostics logo Kappa Bioscience logo Medifast logo Nestle logo NuFace logo Nutri Link logo Obviohealth logo Synlait logo 5 hour Energy logo Ajinomoto logo Bio Origin logo Golden State logo Hourglass logo The A2 Milk Company logo Unilever logo Koa logo inova logo cellcarta logo
Bunge logo Fibronostics logo Kappa Bioscience logo Medifast logo Nestle logo NuFace logo Nutri Link logo Obviohealth logo Synlait logo 5 hour Energy logo Ajinomoto logo Bio Origin logo Golden State logo Hourglass logo The A2 Milk Company logo Unilever logo Koa logo inova logo cellcarta logo

Turn regulatory complexity into clarity
on one intelligent, secure platform

Regalert Graphic

Stay on top of latest global regulatory changes

  • Curated Alerts
  • Over 1700+ subject matter experts
  • AI-Driven Insights augmented with expert knowledge
Learn more

Get tailored, actionable, and timely insights for your business

  • Insights Dashboard
  • Proactive Risk Identification
  • Data-Driven Decision Making
  • Horizon Scanning
  • Report Generation
Learn more
Reginsights Graphic
Askregask Graphic

Manage compliance risks proactively

  • AI-Driven Risk Assessments
  • Ask RegASK
  • Regulatory Change Impact Analysis
Learn more

Improve efficiency and simplify operations with a centralized intelligence platform

  • Conversational AI Copilot
  • Automated Workflows
  • Centralized Knowledge Hub
Learn more
Reggenius Graphic

Case Study: Clinical Research site in UK

Watch how RegASK empowered a UK-based clinical research site to overcome their compliance challenges.

40%
Experienced a significant increase in operational efficiency

50%
Decrease in manual monitoring time

100%
Compliant in clinical trials across multiple regions

Know more
Clinical Research Site In Uk Video Thumbnail

Case Study: Japanese Food Industry

Watch how RegASK helped a leading food industry MNC in Japan transform its compliance processes.

50%
Time freed and improvement in operational efficiency

60%
Time reduced in handling regulatory tasks and inquiries

200
Inquiries per week handled with streamlined workflows

Know more
Japanese Food Industry Video Thumbnail

The 2025 State of Regulatory Affairs and Compliance Report

Drawing on insights from 145+ industry experts, RegASK’s report outlines key regulatory challenges, the role of AI in compliance, and the risks of falling behind.

38%
of regulatory teams feel at risk of non-compliance.

42%
of teams miss compliance deadlines

73%
of executives call for stricter AI regulations.

Know more
The 2025 State Of Regulatory Affairs And Compliance Report

What our customers say about us

Image 64

“RegASK has been a valuable resource for our organization. From alerts and tools that help manage information sharing, to insightful reports, and their outstanding customer service. RegASK is making a positive impact at Oterra and is truly nailing it!”

Renato Ribeiro da Silva

Global Regulatory Affairs Manager

Oterra

Image 63

“RegASK empowers our Regulatory, Sustainability, Legal, and Institutional Affairs teams with speed, clarity, and confidence by streamlining operations and enabling informed action”

 

Ashley Giovinazzo

Senior Manager, Regulatory

Ferrara

Fibronostics Logo Website

“What sets RegASK apart is their practical approach that is catered to you, their flexibility to align with your strategy, and the ability to target deep expertise globally. I highly recommend RegASK. They are true partners in navigating the regulatory maze.”

Shiva Kannan

Chief Operations Officer

Fibronostics

Logo Nuface

“RegASK helped me deep dive into several Asian markets with beauty devices/skincare. This saved me 20+ hours of research and freed me to complete other projects. We had great success in registering our China skincare also. Just wonderful to work with and it is a real partnership!”

Danielle Barker Fernandes
Senior Manager R&D/ R.A.
NuFACE

Naos Greyscale

“We have worked with RegASK on several specific projects which enabled us to clarify internally certain choices we needed to make based on different levels of regulatory risk across countries. This provided an important framework to structure our strategic thinking.”

Béatrice Guelet
International Regulatory Affairs Manager
NAOS

Enterprise-grade Security

Our infrastructure is designed to provide a secure, compliant, and resilient service environment, ensuring that your regulatory compliance needs are met with precision and reliability.

Comprehensive Compliance Coverage

Hosted on Microsoft Azure, RegASK benefits from one of the most secure and reliable cloud platforms in the industry. Azure’s comprehensive compliance coverage helps address regulatory requirements, and its built-in security protects applications and data from external threats.

Our security infrastructure is designed to protect data against unauthorized access or modification and to ensure data is accessible and available. We employ state-of-the-art encryption and secure data handling practices leveraging tools like Microsoft Defender to provide ongoing surveillance of our systems to detect and prevent potential security threats.

RegASK News

Resources

Italy’s AIFA Updates Guidance on OTC and Non-Prescrip…
On February 23, 2026, the Italian Medicines Agency (AIFA) published revised guidance clarifying the definition and classification of over-th…
Read more
UK MHRA Updates Medical Device Registration Guidance wi…
On 20 February 2026, the Medicines & Healthcare products Regulatory Agency published an update to its guidance on registering medical de…
Read more
Bahrain NHRA Publishes Updated Medicine Variations Guid…
On January 21, 2026, the National Health Regulatory Authority (NHRA) published an updated Medicine Variations Guideline for Human Medicines.…
Read more
EU Corrects BPA Rules for Food Contact Materials, Clari…
On 3 February 2026, the European Commission published a correction to its regulation governing the use of bisphenol A (BPA) and related subs…
Read more
EMA Issues Final Elemental Impurity Risk Management Gui…
On February 20, 2026, the European Medicines Agency published final guidance setting out risk management requirements for elemental impuriti…
Read more
USDA Confirms Renewal of 56 Substances Under the Nation…
On February 9, 2026, the United States Department of Agriculture Agricultural Marketing Service (AMS) published a final rule announcing the …
Read more
Germany Issues Guidance on Labeling AI-Generated Advert…
On February 4, 2026, the German Competition Authority published new guidance clarifying how AI-generated advertising content must be labeled…
Read more
FDA Launches Comprehensive Safety Reassessment of BHA i…
On February 10, 2026, the U.S. Food and Drug Administration announced a comprehensive post-market safety reassessment of butylated hydroxyan…
Read more
European Commission Adds Hesperetin Dihydrochalcone to …
On 12 February 2026, the European Commission published a corrigendum to an existing regulation to formally include hesperetin dihydrocha…
Read more

Experience AI-Driven Regulatory Intelligence and Workflow Orchestration.

Book a demo